|
Volumn 105, Issue 3, 2012, Pages 221-222
|
Clinical decision-making and implementation challenges with the AJCC VII staging system for colorectal carcinoma
|
Author keywords
[No Author keywords available]
|
Indexed keywords
EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODY;
TUMOR MARKER;
ADJUVANT THERAPY;
CANCER DIAGNOSIS;
CANCER INVASION;
CANCER LOCALIZATION;
CANCER MORTALITY;
CANCER PATIENT;
CANCER RISK;
CANCER STAGING;
CANCER SURGERY;
CANCER SURVIVAL;
CLINICAL DECISION MAKING;
COLORECTAL CANCER;
COLORECTAL CARCINOMA;
EDITORIAL;
GENE MUTATION;
HETEROZYGOSITY;
HUMAN;
LYMPH NODE METASTASIS;
MICROSATELLITE INSTABILITY;
OVERALL SURVIVAL;
PERINEURIUM;
PHENOTYPE;
PRIORITY JOURNAL;
PROGNOSIS;
SURVIVAL RATE;
TUMOR REGRESSION;
UNITED STATES;
COLORECTAL NEOPLASMS;
COMBINED MODALITY THERAPY;
DECISION MAKING;
HUMANS;
NEOPLASM METASTASIS;
NEOPLASM STAGING;
PROGNOSIS;
|
EID: 84856250499
PISSN: 00224790
EISSN: 10969098
Source Type: Journal
DOI: 10.1002/jso.22086 Document Type: Editorial |
Times cited : (10)
|
References (6)
|